| 缩写名/全名 |
AM J CANCER RES
American Journal of Cancer Research |
||||||||||
| ISSN号 | 2156-6976 | ||||||||||
| 研究方向 | ONCOLOGY- | ||||||||||
| 影响因子 | 2015:3.425, 2016:3.264, 2017:3.998, 2018:4.737, 2019:5.177, | ||||||||||
| 出版国家 | UNITED STATES | ||||||||||
| 出版周期 | |||||||||||
| 年文章数 | 200 | ||||||||||
| 出版年份 | 0 | ||||||||||
| 是否OA | Yes | ||||||||||
| 审稿周期(仅供参考) | |||||||||||
| 录用比例 | |||||||||||
| 投稿链接 | https://e-century.us/submission/ | ||||||||||
| 投稿官网 | http://www.ajcr.us/ | ||||||||||
| h-index | 20 | ||||||||||
| CiteScore | |||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2156-6976%5BISSN%5D | ||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Nuclear factor-erythroid 2-related factor 3 (NRF3) is low expressed in colorectal cancer and its down-regulation promotes colorectal cancer malignance through activating EGFR and p38/MAPK. Author: Zhou S1,2, Li Y2, Lu J1, Chen C1, Wang W2, Wang L3, Zhang Z1, Dong Z4, Tang F1,2. Journal: Am J Cancer Res. 2019 Mar 1;9(3):511-528. eCollection 2019. PubMed |
| 2. | Respiratory hyperoxia reverses immunosuppression by regulating myeloid-derived suppressor cells and PD-L1 expression in a triple-negative breast cancer mouse model. Author: Qian X1, Zhang Q1, Shao N1, Shan Z1, Cheang T1, Zhang Z1, Su Q2, Wang S1, Lin Y1. Journal: Am J Cancer Res. 2019 Mar 1;9(3):529-545. eCollection 2019. PubMed |
| 3. | Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma. Author: Ding X1, Zhang Y2, Huang T1, Xu G1, Peng C1, Chen G3, Kong B1,4, Friess H4, Shen S1, Lv Y1, Roberts LR5, Wang L1, Zou X2. Journal: Am J Cancer Res. 2019 Mar 1;9(3):546-561. eCollection 2019. PubMed |
| 4. | Magnetic resonance imaging monitoring therapeutic response to dendritic cell vaccine in murine orthotopic pancreatic cancer models. Author: Pan L1,2, Shang N2, Shangguan J2, Figini M2, Xing W1, Wang B3, Sun C4, Yang J2, Zhang Y2, Hu S2, Ma Q2, Wang J2,5, Velichko Y2,6, Yaghmai V2,6, Benson AB 3rd6,7, Zhang Z2,6. Journal: Am J Cancer Res. 2019 Mar 1;9(3):562-573. eCollection 2019. PubMed |
| 5. | Chidamide, a novel histone deacetylase inhibitor, inhibits multiple myeloma cells proliferation through succinate dehydrogenase subunit A. Author: Sun Y1, Li J1, Xu Z1, Xu J1, Shi M1, Liu P1. Journal: Am J Cancer Res. 2019 Mar 1;9(3):574-584. eCollection 2019. PubMed |
| 6. | Decreased miR-124-3p promoted breast cancer proliferation and metastasis by targeting MGAT5. Author: Yan G1,2, Li Y3, Zhan L1, Sun S4, Yuan J4, Wang T4, Yin Y4, Dai Z4, Zhu Y4, Jiang Z2, Liu L5, Fan Y6, Yang F4, Hu W1. Journal: Am J Cancer Res. 2019 Mar 1;9(3):585-596. eCollection 2019. PubMed |
| 7. | Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells. Author: Han Y1,2, Chen MK2,3, Wang HL4,5, Hsu JL2, Li CW2, Chu YY2, Liu CX2, Nie L2, Chan LC2,3, Yam C2,6,3, Wang SC4,5, He GJ1, Hortobagyi GN6, Tan XD7, Hung MC2,3,4,5. Journal: Am J Cancer Res. 2019 Mar 1;9(3):608-618. eCollection 2019. PubMed |
| 8. | Effect of EGFR gene polymorphism on efficacy of chemotherapy combined with targeted therapy for non-small cell lung cancer in Chinese patients. Author: Wang Y1, Xie S1, He B1. Journal: Am J Cancer Res. 2019 Mar 1;9(3):619-627. eCollection 2019. PubMed |
| 9. | Circular RNAs: an emerging landscape in tumor metastasis. Author: Shen B1,2, Wang Z3,2, Li Z1,2, Song H2, Ding X2. Journal: Am J Cancer Res. 2019 Apr 1;9(4):630-643. eCollection 2019. PubMed |
| 10. | MicroRNA-874 functions as a tumor suppressor in rhabdomyosarcoma by directly targeting GEFT. Author: Shang H1, Liu Y1, Li Z1, Liu Q1, Cui W1, Zhang L1, Pang Y1, Liu C1, Li F1,2. Journal: Am J Cancer Res. 2019 Apr 1;9(4):668-681. eCollection 2019. PubMed |
|
|
